Merck KGaA, the German healthcare and technology conglomerate, has announced that it is in advanced negotiations to acquire ...

Germany's Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.

Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

EMD Electronics, the North American pigments division of Merck KGaA, Darmstadt, Germany, has launched Ronaflux® cosmetic ...

AQILION AB (publ) announces that the Company has resumed development of the its TAK1 program as the company has regained the control and ownership of the program. After reviewing and analysing the ...

In the wake of AI, unprecedented demand for data and computing power is outstripping capabilities. This will drive the ...

NORTHAMPTON, MA / ACCESS Newswire / January 29, 2025 / Celebrating its sixth annual tour, the Curiosity Cube from MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, ...